CN109809987A - A kind of new synthetic method of loxoprofen sodium - Google Patents
A kind of new synthetic method of loxoprofen sodium Download PDFInfo
- Publication number
- CN109809987A CN109809987A CN201711166565.7A CN201711166565A CN109809987A CN 109809987 A CN109809987 A CN 109809987A CN 201711166565 A CN201711166565 A CN 201711166565A CN 109809987 A CN109809987 A CN 109809987A
- Authority
- CN
- China
- Prior art keywords
- toluene
- synthetic method
- room temperature
- sodium
- loxoprofen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention belongs to organic synthesis fields, and in particular to a kind of new synthetic method of loxoprofen sodium.The synthetic method synthetic method is reacted through 4 steps and is made using 2- (4- bromomethyl) phenylpropionic acid as raw material.The present invention uses a kind of new synthetic method of loxoprofen sodium, and yield improves, and industrial prospect is good.
Description
Technical field
The invention belongs to organic synthesis fields, and in particular to a kind of new synthetic method of loxoprofen sodium.
Background technique
Loxoprofen sodium (1oxoprofen sodium) is a kind of important 2- phenylpropionic acid Nonsteroidal anti-inflammatory analgesia
Medicine is listed by total company, Japan three in exploitation in 1986, anti-inflammatory, analgesia, refrigeration function with higher, and alimentary canal is bad
React small.Compared with clinically similar drugs, feature is mainly reflected in loxoprofen sodium: stronger (clinical effectiveness is good), faster
(taking orally 30 minutes plasma concentration, that is, reach to peak values), safer (Small side effects).Another kind of feature is wide indications, clinically can be wide
After the general anti-inflammatory and antalgic for being used for rheumatoid arthritis, pain in the loins, scapulohumeral periarthritis, neck shoulder wrist syndrome etc., operation, wound and after extraction
Easing pain and diminishing inflammation and the antipyretic-antalgic of acute upper respiratory tract inflammation etc..
Currently, the synthetic route of loxoprofen sodium is mostly more complicated, synthesis yield is low, and bulk pharmaceutical chemicals are expensive and are not easy
It obtains.
Summary of the invention
The purpose of the present invention is to provide a kind of new synthetic method of loxoprofen sodium, this method high income, synthesis is simple,
It is suitble to industrialized production.
To achieve the goals above, the present invention adopts the following technical scheme: a kind of new synthetic method of loxoprofen sodium, is somebody's turn to do
Synthetic method is reacted through 4 steps and is made using 2- (4- bromomethyl) phenylpropionic acid as raw material.
A kind of new synthetic method of loxoprofen sodium, the synthetic method include the following steps:
Step 1: by 24.3 g 2- (4- bromomethyl) phenylpropionic acid, 64 g methanol investment reaction flask, stirring evenly, 0
The 19.6 g concentrated sulfuric acids are added dropwise at~5 DEG C, 50 m L water are added, with 200 m L toluene in 6 h that are added dropwise that the reaction was continued
Extraction, layering, organic layer are washed with saturated sodium carbonate solution, are washed to neutrality, dry, are concentrated to dryness, are obtained 25.2 g
Compound 2- (4- 2-bromomethylphenyl) methyl propionate (I)；Step 2: by l5.7 g 2- carbethoxyl group cyclopentanone, 50 m L
Toluene is put into reaction flask, is stirred evenly, and 5.2 g of potassium carbonate is added, and is warming up to reflux, and the 50 above-mentioned preparations of m L are added dropwise
25.7 g compound I toluene solution, drop finishes, continues to be stirred to react 12 h, be down to room temperature, 50 m L water are added, point
Layer, water layer is 3.0-4.0 with 8.0 m olL salt acid for adjusting pH value, is extracted with 50 lnL toluene, and toluene is washed
Layer, reduced pressure are evaporated off toluene, obtain 29 g compound 2- [4- (1- carbethoxyl group -2- oxo -1- cyclopentyl-methyl) benzene
Base] methyl propionate (II)；Step 3: being 48% hydrobromic acid, 30 mL by 31.8 g compound II, 70 mL mass fractions
Glacial acetic acid is put into reaction flask, and 8 h of back flow reaction is cooled to room temperature, and 50 mL water are added, and is extracted with 100 mL toluene,
Toluene layer saturated common salt water washing, is concentrated to dryness, with ethyl acetate-hexane (volume ratio 1:2) crystallization, mistake
It is sour (III) to obtain 20g loxoprofen for filter, drying；
Step 4: 24.6 g loxoprofens sour (III), 100 mL ethyl alcohol being placed in a reaction flask, 2 mol/L are added dropwise at room temperature
Sodium hydrate aqueous solution to pH value be 7.0-8.0, drop finishes, and is stirred at room temperature 3 h, and crystallization, filtering obtains crude product, uses
Ethyl alcohol-isopropyl ether recrystallization, obtains loxoprofen sodium.
Compared with prior art, effect of the invention is that: the present invention use loxoprofen sodium new method, not only reduce
Cost protects environment, and easy to operate, convenient post-treatment, high income, and synthesis is simple, is suitble to industrialized production.
Specific embodiment
Embodiment 1
A kind of new synthetic method of loxoprofen sodium, the synthetic method include the following steps:
Step 1: by 24.3 g 2- (4- bromomethyl) phenylpropionic acid, 64 g methanol investment reaction flask, stirring evenly, 0
The 19.6 g concentrated sulfuric acids are added dropwise at~5 DEG C, 50 m L water are added, with 200 m L toluene in 6 h that are added dropwise that the reaction was continued
Extraction, layering, organic layer are washed with saturated sodium carbonate solution, are washed to neutrality, dry, are concentrated to dryness, are obtained 25.2 g
Compound 2- (4- 2-bromomethylphenyl) methyl propionate (I) is colourless oil liquid, yield 98%, H PL C detection purity
It is 96%.
1H-NMR (CDCl3): 1.47 (Hz of d, 3H, J=7.5), 3.63 (S, 3H), 3.72 (q, H, J=
7.5 Hz), 4.45 (S, 2H), 7.26 (dd, 2H, J=1.5,6.5 H z), 7.33 (dd, 2H, J=1.5,
6.5 Hz) .Step 2: by l5.7 g 2- carbethoxyl group cyclopentanone, 50 m L toluene investment reaction flask, stir evenly,
5.2 g of potassium carbonate is added, is warming up to reflux, the toluene solution of 25.7 g compound I of the 50 above-mentioned preparations of m L, drop is added dropwise
Finish, continue to be stirred to react 12 h, be down to room temperature, 50 m L water, layering, 8.0 m olL hydrochloric acid tune of water layer are added
Section pH value is 3.0-4.0, is extracted with 50 mL toluene, and toluene layer is washed, and reduced pressure is evaporated off toluene, obtains 29 g
Compound 2- [4- (1- carbethoxyl group -2- oxo -1- cyclopentyl-methyl) phenyl] methyl propionate (II) is yellow oily liquid
, it is 92% that yield 9l%, H PLC, which detects purity,；
1H-NMR (CDCl3): 1.25 (Hz of d, 3H, J=7.5), 1.47 (H z of d, 3H, J=7.0), 1.63-
1.65 (m, 1H), 1. 89-1.96 (m, 2H), 2.03~2.O7 (m, 1H), 2.39-2.43 (m, 2H
), 3.o6 (I-Iz of d, 1H, J=14.0), 3.19 (d, 1H ,=l3.5 H z), 3.65 (S, 3H),
3.68 (H z of q, 1H, J=7.5), 4. 16 (H z of q, 2H, J=7.5), 7.09 (d, 2H, J=8.0
H z), 7.18 (H z of d, 2H, J=8.0).
Step 3: being 48% hydrobromic acid, 30 mL glacial acetic acid investment by 31.8 g compound II, 70 mL mass fractions
In reaction flask, 8 h of back flow reaction is cooled to room temperature, and 50 mL water are added, and is extracted with 100 mL toluene, and toluene layer is used full
And brine It, it is concentrated to dryness, with ethyl acetate-hexane (volume ratio 1:2) crystallization, filters, drying,
It is sour (III) to obtain 20g loxoprofen, is white solid, yield 81%, HPLC detection level is 98%, mp108-110
℃ ；
1H-NMR (CDCl3): 1.49 (H z of d, 3H, J=7.0), 1.51-1.56 (m, 1H), 1.7O-1.
74 (m, 1H), 1.94-1.98 (ITI, 1H), 2.07-2.13 (m, 2H), 2.3l-2.34 (m, 2H), 2.5l
(dd, 1H, J=4.0,14.0 H z), 3.13 (dd, 1H, J: 4.0,14.0 H z), 3.70 (q, 1H, J=
7.0 H z), 7.13 (H z of d, 2H, J=8.0), 7.23 (H z of d, 2H, J=8.0).
Step 4: 24.6 g loxoprofens sour (III), 100 mL ethyl alcohol being placed in a reaction flask, 2 are added dropwise at room temperature
The sodium hydrate aqueous solution of mol/L to pH value is 7.0-8.0, and drop finishes, and 3 h, crystallization are stirred at room temperature, and filtering obtains slightly
Product are recrystallized with ethyl alcohol-isopropyl ether, obtain 25 g of loxoprofen sodium, are white solid, yield 82%, H PLC
Detection level is 196-198 DEG C of 99%, mp.
The foregoing is only a preferred embodiment of the present invention, is not intended to restrict the invention, for the skill of this field
For art personnel, the invention may be variously modified and varied.All within the spirits and principles of the present invention, made any to repair
Change, equivalent replacement, improvement etc., should all be included in the protection scope of the present invention.
Claims (2)
1. a kind of new synthetic method of loxoprofen sodium, which is characterized in that the synthetic method is with 2- (4- bromomethyl) phenylpropionic acid
For raw material, reacts and be made through 4 steps.
2. a kind of new synthetic method of loxoprofen sodium according to claim 1, which is characterized in that the synthetic method includes
Following steps:
Step 1: by 2- (4- bromomethyl) phenylpropionic acid, methanol investment reaction flask, stirring evenly, be added dropwise at 0~5 DEG C
The concentrated sulfuric acid, 6 h that are added dropwise that the reaction was continued are added water, are extracted with toluene, is layered, organic layer is washed with saturated sodium carbonate solution
It washs, is washed to neutrality, it is dry, it is concentrated to dryness, obtains compound 2- (4- 2-bromomethylphenyl) methyl propionate (I)；
Step 2: by 2- carbethoxyl group cyclopentanone, toluene investment reaction flask, stirring evenly, potassium carbonate is added, is warming up to back
The toluene solution of the compound I of above-mentioned preparation is added dropwise in stream, and drop finishes, continues to be stirred to react 12 h, is down to room temperature, and water is added,
Layering, water layer is 3.0-4.0 with salt acid for adjusting pH value, is extracted with toluene, and toluene layer is washed, and toluene is evaporated off in reduced pressure,
Obtain 29 g compound 2- [4- (1- carbethoxyl group -2- oxo -1- cyclopentyl-methyl) phenyl] methyl propionate (II)；Step
3: by compound II, mass fraction be hydrobromic acid, glacial acetic acid is put into reaction flask, and 8 h of back flow reaction is cooled to room temperature, adds
Enter water, extracted with toluene, toluene layer saturated common salt water washing is concentrated to dryness, with ethyl acetate-hexane crystallization, mistake
It is sour (III) to obtain loxoprofen for filter, drying；
Step 4: loxoprofen sour (III), ethyl alcohol being placed in a reaction flask, the sodium hydrate aqueous solution being added dropwise at room temperature to pH
Value is 7.0-8.0, and drop finishes, and 3 h, crystallization are stirred at room temperature, and filtering obtains crude product, is recrystallized with ethyl alcohol-isopropyl ether, obtains Lip river
Suo Luofen sodium.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711166565.7A CN109809987A (en) | 2017-11-21 | 2017-11-21 | A kind of new synthetic method of loxoprofen sodium |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711166565.7A CN109809987A (en) | 2017-11-21 | 2017-11-21 | A kind of new synthetic method of loxoprofen sodium |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109809987A true CN109809987A (en) | 2019-05-28 |
Family
ID=66600367
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201711166565.7A Pending CN109809987A (en) | 2017-11-21 | 2017-11-21 | A kind of new synthetic method of loxoprofen sodium |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109809987A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113387792A (en) * | 2021-07-12 | 2021-09-14 | 迪嘉药业集团有限公司 | Synthetic method of loxoprofen sodium process impurity |
-
2017
- 2017-11-21 CN CN201711166565.7A patent/CN109809987A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113387792A (en) * | 2021-07-12 | 2021-09-14 | 迪嘉药业集团有限公司 | Synthetic method of loxoprofen sodium process impurity |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102020633B (en) | Method for preparing 1-(3,5- dichloropyridine-2-yl)-pyrazolecarboxamide compounds | |
| CN101967145B (en) | Method for preparing antithrombotic medicament apixaban | |
| CN104447600B (en) | A kind of Preparation Method And Their Intermediate impurity of Parecoxib sodium compound, preparation method and application | |
| CN108997253B (en) | Mandelic acid derivatives containing 1,3, 4-oxadiazole thioether and application thereof | |
| CN108864111A (en) | A kind of Tr*ger ' s base class compound and the preparation method and application thereof containing benzimidazole | |
| CN106188040B (en) | A kind of Fevipiprant and its intermediate preparation method | |
| US20050222255A1 (en) | Process for producing trans-4-amino-1-cyclohexanecarboxilic acid derivative | |
| CN109809987A (en) | A kind of new synthetic method of loxoprofen sodium | |
| CN103896700A (en) | Preparation method of ezetimibe chiral intermediate | |
| CN107935930A (en) | 3 difluoromethyl 1H pyrazoles of a kind of 1 methyl, 4 amide derivatives and preparation method and application | |
| CN102070484B (en) | Method for preparing prilocainum or hydrochloride thereof | |
| CN106883192B (en) | The synthetic method of the benzoic acid derivative of nitrogenous class heterocyclic antineoplastic pharmaceutical actives oxazolyl modification | |
| CN107646855B (en) | Application of thiazole compound containing piperidine in preparation of bactericide and preparation method thereof | |
| CA2855021A1 (en) | Process for the preparation of roflumilast | |
| CN107098866A (en) | The method for splitting of medicine Lesinurad axial chirality enantiomers | |
| WO2015027893A1 (en) | Dabigatran etexilate synthesizing method | |
| CN101456843B (en) | Synthetic method of 5-(4-chlorphenyl)-1-(2,4-dichlorobenzene)-4-methylpyrazole-3-carboxyl acid | |
| CN104926807A (en) | Rivaroxaban related substance 'diamine' and synthesis method thereof | |
| CN105085371B (en) | (S) { 1 (chloro-carbonic acid ester group) 2 [2 (1,3 dioxy iso-indoles) base] ethyl } halide salt and preparation method thereof | |
| CN105218519A (en) | A kind of preparation method of dabigatran etexilate intermediate | |
| Mistry et al. | Conventional and microwave induced synthesis of various pyrimidine and isoxazole derivatives from 1-{4'-[(4''-methylpiperazinyl) diazenyl] phenyl}-3-(substitutedphenyl) prop-2-en-1-one and studies of their antimicrobial activity | |
| CN105085431B (en) | 4 (4 first ammonia thiazolinyl phenyl) 3 morpholones and preparation method thereof | |
| CN108912124A (en) | A method of utilizing the ionic liquid-catalyzed preparation compound of pyrazole heterocycle containing sulfuryl | |
| JPS6143173A (en) | Novel pyrimidine drivative and preparation thereof | |
| CN111440059B (en) | Synthetic method of loxoprofen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20190528 |